The new study, published in PLOS ONE, included registry data from nearly 4,500 patients. While COVID-19 patients faced a heightened risk of adverse cardiovascular outcomes early on, many of those risks faded after approximately one month. 

AVS, a Michigan-based medical device company, has said the funding will help accelerate research on its new Pulse P-IVL system. One clinical trial is already underway. 

The Kentucky physician fought back against the allegations, but his attorney's arguments were not effective enough to sway the judge. 

Here are links to more information on every late-breaking presentation at ACC.23.

A new analysis in Circulation: Cardiovascular Interventions examined rehospitalization rates after AVR, noting that they are consistently associated with worse outcomes and a higher risk of patient mortality.

Christine Seidman, MD, director of the cardiovascular genetics program at Brigham & Women’s Hospital, spoke to us about using genetics to crack the code of cardiovascular disease. 

Even after adjusting for factors such as income, comorbidities and stroke severity indicators, a prolonged length of stay was more common for Black patients.

Edward T.A. Fry, MD, president of the American College of Cardiology and a veteran cardiologist, shared his perspective on the many ways cardiologists can work to limit medical misinformation and disinformation. 

Gwendolyn Bryant-Smith, MD, division chief of breast imaging and associate director for diversity, equity and inclusion at the Winthrop P. Rockefeller Cancer Institute, University of Arkansas, discussed how her center addressed health inequities in mammography.

The UK's Home Secretary recently proposed the use of X-ray, CT and/or MRI for age checks to determine which migrants are, in fact, children and which ones might be posing as children in an attempt to remain in the country.